APPROVAL OF THE STUDY Sample Clauses

APPROVAL OF THE STUDY. 9.1 The University shall approve the Learning Agreement prior to the mobility, for which the financial support is granted under this Agreement. The University, the sending organization, and the student shall pre-approve the Learning Agreement. 9.2 Within one month after the arrival of the student at the University, the Parties shall terminate and formally document any necessary changes to the Learning Agreement, which the student finds out after arrival at the University. The Parties shall formally and without any delay approve any other changes (the University, the sending organization, and the student).
Sample 1Sample 2Sample 3See All (8)
AutoNDA by SimpleDocs
APPROVAL OF THE STUDY. 10.1. The university shall approve the Learning Agreement prior to the mobility, for which the financial support is granted under this Agreement. The host University, the sending organization, and the student shall pre- approve the Learning Agreement. 10.2. Within one month after the arrival of the student at the host organization, the Parties shall terminate and formally document any necessary changes to the Learning Agreement, which the student finds out after arrival at the host organization. The Parties shall formally and without any delay approve any other changes (the University, the host organization, and the student). 10.3. The host organization shall issue the student a transcript of their assessment in accordance with this Agreement after the successful completion of the mobility. 10.4. The University is entitled to refuse to approve the mobility of the student in case the student fails to fulfil the requirements of the host organization or fails to fulfil the conditions required by the host University.
Sample 1Sample 2Sample 3See All (6)
APPROVAL OF THE STUDY. 11.1. The university shall approve the Learning Agreement prior to the mobility, for which the financial support is granted under this Agreement. The University, the host organization, and the student shall pre-approve the Learning Agreement. 11.2. Within one month after the arrival of the student at the host organization, the Parties shall terminate and formally document any necessary changes to the Learning Agreement, which the student finds out after arrival at the host organization. The Parties shall formally and without any delay approve any other changes (the University, the host organization, and the student). 11.3. The host organization shall issue the student a transcript of their assessment in accordance with this Agreement after the successful completion of the mobility. 11.4. The student shall obtain at least 15 credits (the recommended number of credits obtained is 30) per semester at the receiving organization abroad. If the student obtains a smaller than the minimum number of credits (that is, less than 15 credits) per semester, the University becomes entitled to demand from the student remittance of the aliquot part of the grant according to the following table: 15 credits remittance of 0% of the grant awarded 14 credits remittance of 20% of the grant awarded 13 credits remittance of 40% of the grant awarded 12 credits remittance of 60% of the grant awarded 11 credits remittance of 80% of the grant awarded 10 credits or less Remittance of 100% of the grant awarded
Sample 1Sample 2Sample 3See All (5)
APPROVAL OF THE STUDY. 11.1. The university shall approve the Learning Agreement prior to the mobility, for which the financial support is granted under this Agreement. The University, the host organization, and the student shall pre-approve the Learning Agreement. 11.2. Within one month after the arrival of the student at the host organization, the Parties shall terminate and formally document any necessary changes to the Learning Agreement, which the student finds out after arrival at the host organization. The Parties shall formally and without any delay approve any other changes (the University, the host organization, and the student). 11.3. The host organization shall issue the student a transcript of their assessment in accordance with this Agreement after the successful completion of the mobility. 11.4. The University is entitled to refuse to approve the mobility of the student in case the student fails to fulfil the requirements of the host organization or fails to fulfil the conditions required by the University, especially the insufficient number of credits in accordance with Directive No. 3/2010 for the study of UPJŠ students at international universities under the Erasmus programme dated 31/08/2010. 11.5. The university is entitled to claim the recovery of the financial support under this Agreement from the student who fails the courses attended during their stay abroad (not being awarded the sufficient number of credits) in accordance with Directive 3/2010 for the study of UPJŠ students at international universities under the Erasmus+ sub-programme dated 31/08/2010. Exceptions are those students who could not attend the courses due to force majeure for the ERASMUS+ at the University.
Sample 1Sample 2
APPROVAL OF THE STUDY. 10.1. The university shall approve the Learning Agreement prior to the mobility, for which the financial support is granted under this Agreement. The host University, the sending organization, and the student shall pre- approve the Learning Agreement. 10.2. Within one month after the arrival of the student at the host organization, the Parties shall terminate and formally document any necessary changes to the Learning Agreement, which the student finds out after arrival at the host organization. The Parties shall formally and without any delay approve any other changes (the University, the host organization, and the student). 10.3. The host organization shall issue the student a transcript of their assessment in accordance with this Agreement after the successful completion of the mobility. 10.4. The University is entitled to refuse to approve the mobility of the student in case the student fails to fulfil the requirements of the host organization or fails to fulfil the conditions required by the host University. 10.5. The university is entitled to claim the recovery of the financial support under this Agreement from the student who fails the courses attended during their stay abroad (not being awarded the sufficient number of credits) Exceptions are those students who could not attend the courses due to force majeure for the ERASMUS+ at the host University.
Sample 1
APPROVAL OF THE STUDY. 9.1 The University shall approve the Learning Agreement prior to the mobility, for which the financial support is granted under this Agreement. The University, the sending organization, and the student shall pre-approve the Learning Agreement. 9.2 Within one month after the arrival of the student at the University, the Parties shall terminate and formally document any necessary changes to the Learning Agreement, which the student finds out after arrival at the University. The Parties shall formally and without any delay approve any other changes (the University, the sending organization, and the student). 9.3 The University shall issue the student a transcript of their assessment in accordance with this Agreement after the successful completion of the mobility. 9.4 The University is entitled to refuse to approve the mobility of the student in case the student fails to fulfil the conditions required by the University. 9.5 Mobility participants will share their mobility experiences within their capabilities based on the guidelines of the European Union and will promote the Erasmus+ program to enable other people (including young people) to benefit from this experience.
Sample 1

Related to APPROVAL OF THE STUDY

  • Approval of Agreement The Board of Directors of the Company has authorized the execution and delivery of this Agreement by the Company and has approved this Agreement and the transactions contemplated hereby.

  • Approval of Plan Approval of the Plan by the Commissioner of Internal Revenue as referred to in 17.1 means a continuing approval sufficient to establish that the Plan and related trust(s) are at all times qualified and exempt from income tax under Section 401(a) and other applicable provisions of the Internal Revenue Code of 1986, and that contributions made by the Company under the Plan are deductible for income tax purposes in accordance with law. The cognizant governmental authorities referred to in 17.1 include, without limitation, the Department of Labor, the Pension Benefit Guaranty Corporation and the Securities and Exchange Commission, and their approval means their confirmation with respect to any matter within their regulatory authority that the Plan does not conflict with applicable law.

  • Approval of Documents The form and substance of all certificates, instruments and other documents required to be delivered to the Seller under this Agreement shall be reasonably satisfactory in all respects to the Seller and its counsel.

  • Waiver of Notice; Approval of Meeting; Approval of Minutes The transactions of any meeting of Limited Partners, however called and noticed, and whenever held, shall be as valid as if it had occurred at a meeting duly held after regular call and notice, if a quorum is present either in person or by proxy. Attendance of a Limited Partner at a meeting shall constitute a waiver of notice of the meeting, except when the Limited Partner attends the meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened; and except that attendance at a meeting is not a waiver of any right to disapprove the consideration of matters required to be included in the notice of the meeting, but not so included, if the disapproval is expressly made at the meeting.

  • Regulatory Approval 25.1 The Parties understand and agree that this Agreement and any amendment or modification hereto will be filed with the Commission for approval in accordance with Section 252 of the Act and may thereafter be filed with the FCC. The Parties believe in good faith and agree that the services to be provided under this Agreement are in the public interest. Each Party covenants and agrees to fully support approval of this Agreement by the Commission or the FCC under Section 252 of the Act without modification.

  • Approval of Documentation The form and substance of all certificates, instruments, opinions, and other documents delivered to Buyer under this Agreement shall be satisfactory in all reasonable respects to Buyer and its counsel.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Commercialization Plan (a) Not later than three [***] after submission of Regulatory Filings for each Product in each country of the Territory, Licensee will provide to the JCC for review its initial Commercialization Plan for each Product for each country in the Territory. Such initial Commercialization Plan will describe Licensee’s plans for activities to be conducted for such Product for such country. Each Commercialization Plan shall include the details of obligations to be performed by Licensee to achieve the specific activities that are applicable to the stage of [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Commercialization (e.g., pre-launch, launch planning, launch, or post-launch) of the applicable Product during the time period covered by such Commercialization Plan and subsequent time periods. (b) Prior to the First Commercial Sale for such Product in such country, Licensee will provide to the JCC for review an updated Commercialization Plan for such Product for such country. Such updated Commercialization Plan will include, but not be limited to, Licensee’s updated plans for activities to be conducted for such Product for such country prior to launch as well as activities to be conducted in connection with such launch. (c) Promptly after each anniversary of the First Commercial Sale of such Product during the Term, Licensee will provide to the JCC for review updated Commercialization Plans for such Product for such country. Such further updated Commercialization Plan will include, but not be limited to, Licensee’s plans for Commercialization activities for such Product and such country for the twelve (12) month period following the date of delivery of such Commercialization Plan. No Commercialization Plan may be implemented by Licensee if [***]. Each Commercialization Plan shall be consistent with and shall not contradict the terms of this Agreement [***], and in the event of any inconsistency between the Commercialization Plan and this Agreement, the terms of this Agreement shall prevail. Notwithstanding the foregoing, if a [***], Licensee shall [***] and shall promptly [***].

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!